Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 24 11:57AM ET
Dollar change
Percentage change
IndexRUT P/E- EPS (ttm)-1.26 Insider Own9.13% Shs Outstand148.63M Perf Week-37.43%
Market Cap704.88M Forward P/E- EPS next Y-0.86 Insider Trans21.76% Shs Float135.05M Perf Month-49.60%
Income-80.74M PEG- EPS next Q-0.19 Inst Own45.06% Short Float8.74% Perf Quarter18.27%
Sales58.44M P/S12.06 EPS this Y17.45% Inst Trans-1.60% Short Ratio5.08 Perf Half Y104.42%
Book/sh0.79 P/B5.98 EPS next Y-3.15% ROA-40.23% Short Interest11.81M Perf Year-23.51%
Cash/sh1.32 P/C3.60 EPS next 5Y- ROE-127.64% 52W Range2.00 - 11.31 Perf YTD6.33%
Dividend Est.- P/FCF- EPS past 5Y8.38% ROI-46.69% 52W High-58.07% Beta1.44
Dividend TTM- Quick Ratio6.59 Sales past 5Y121.20% Gross Margin90.96% 52W Low137.72% ATR (14)0.58
Dividend Ex-Date- Current Ratio6.66 EPS Y/Y TTM-9.25% Oper. Margin-140.96% RSI (14)17.21 Volatility13.94% 7.61%
Employees267 Debt/Eq0.92 Sales Y/Y TTM13.49% Profit Margin-138.14% Recom1.38 Target Price15.50
Option/ShortYes / Yes LT Debt/Eq0.90 EPS Q/Q-71.51% Payout- Rel Volume1.56 Prev Close5.00
Sales Surprise-5.74% EPS Surprise-18.12% Sales Q/Q5.16% EarningsMar 11 AMC Avg Volume2.32M Price4.74
SMA20-38.73% SMA50-44.95% SMA200-3.65% Trades Volume1,478,136 Change-5.15%
Date Action Analyst Rating Change Price Target Change
Feb-09-24Initiated BofA Securities Buy $15
Apr-21-23Initiated Robert W. Baird Outperform $18
Aug-10-22Resumed Berenberg Buy $15
Aug-10-21Upgrade H.C. Wainwright Neutral → Buy $17
Dec-28-20Downgrade H.C. Wainwright Buy → Neutral
Dec-17-20Initiated Berenberg Buy $27
Nov-13-20Reiterated Raymond James Strong Buy $15 → $25
Aug-10-20Reiterated H.C. Wainwright Buy $10 → $13
Mar-03-20Upgrade Raymond James Outperform → Strong Buy
May-21-19Reiterated H.C. Wainwright Buy $12 → $9
Today 08:30AM
Apr-18-24 03:37PM
Apr-16-24 04:30PM
07:00AM Loading…
Apr-15-24 07:00AM
Apr-09-24 09:35AM
Apr-06-24 10:00AM
Apr-01-24 10:09AM
Mar-26-24 07:30AM
Mar-13-24 06:38AM
Mar-12-24 09:55AM
Mar-11-24 05:32PM
04:26PM Loading…
Mar-05-24 07:30AM
Mar-01-24 06:30PM
Feb-29-24 08:52AM
Feb-28-24 01:40PM
Feb-26-24 12:00PM
Feb-25-24 02:02PM
Feb-22-24 07:32AM
Feb-21-24 09:55AM
Feb-19-24 09:00AM
Feb-18-24 08:00PM
08:00AM Loading…
Feb-15-24 08:00AM
Feb-13-24 07:37AM
Feb-12-24 06:27AM
Jan-30-24 09:55AM
Jan-25-24 08:00AM
Jan-10-24 08:44AM
Jan-03-24 01:15PM
Dec-18-23 04:01PM
Dec-13-23 10:09PM
Nov-08-23 05:18PM
Nov-07-23 06:47PM
Nov-01-23 08:00AM
Oct-31-23 09:00AM
Oct-30-23 09:35PM
Oct-24-23 08:00AM
Oct-03-23 04:01PM
Sep-19-23 09:00PM
Sep-06-23 08:00AM
Aug-09-23 08:00AM
Aug-08-23 11:13AM
Aug-07-23 07:15PM
Jul-24-23 08:00AM
Jul-14-23 06:59AM
Jul-13-23 09:00AM
Jul-12-23 08:00AM
Jun-10-23 06:30PM
Jun-07-23 08:00AM
Jun-05-23 04:01PM
Jun-02-23 09:37AM
Jun-01-23 08:00AM
May-09-23 11:42AM
May-08-23 06:15PM
May-04-23 09:50AM
Apr-28-23 08:00AM
Apr-24-23 08:00AM
Apr-14-23 04:01PM
Apr-07-23 08:49AM
Mar-11-23 07:22AM
Mar-08-23 08:50AM
Mar-07-23 08:40AM
Mar-06-23 05:15PM
Feb-28-23 08:00AM
Feb-27-23 05:15PM
Feb-21-23 08:00AM
Feb-16-23 05:15PM
Feb-13-23 05:52AM
Feb-11-23 08:00AM
Jan-06-23 08:00AM
Dec-24-22 07:34AM
Nov-13-22 07:10AM
Nov-08-22 08:00AM
Nov-07-22 05:25PM
Oct-24-22 06:00AM
Oct-17-22 08:11AM
Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SUMMER ROAD LLC10% OwnerFeb 26 '24Buy7.52930,8517,000,0008,591,401Feb 27 04:43 PM
Mattessich Antony C.President and CEOJan 31 '24Sale4.9518,33890,773427,943Feb 02 07:00 PM
Ozden Rabia GursesChief Medical OfficerJan 31 '24Sale4.957,76438,43292,767Feb 02 07:02 PM
Strassburger Philip C.General CounselJan 31 '24Sale4.956,83133,813109,218Feb 02 07:01 PM
Notman DonaldChief Financial OfficerJan 31 '24Sale4.956,43331,843139,932Feb 02 07:03 PM
White Christopher GChief Business OfficerJan 31 '24Sale4.955,14725,47889,619Feb 02 07:01 PM
SUMMER ROAD LLC10% OwnerDec 14 '23Buy3.251,538,4614,999,9987,660,550Dec 18 04:52 PM
Mattessich Antony C.President and CEOAug 30 '23Buy3.816,50024,7656,500Sep 05 08:27 AM
Ozden Rabia GursesChief Medical OfficerJul 07 '23Sale4.938324,102100,531Jul 11 08:00 PM